Published: May 28, 2026
Written by Klarity Editorial Team
Published: May 28, 2026

If you’re living with bipolar disorder, you’ve probably wondered whether you can access treatment from home. The short answer is yes—in most cases, you can legally receive bipolar medications like Lithium, Lamictal (lamotrigine), and Seroquel (quetiapine) through telehealth across all 50 states. But the details matter, especially as federal and state regulations continue to evolve.
This comprehensive guide breaks down everything you need to know about the legality of telehealth prescribing for bipolar disorder, including federal rules, state-by-state differences, and what to expect from your virtual treatment.
Many people confuse telehealth prescribing rules for ADHD medications (like Adderall) with those for bipolar medications. Here’s the critical distinction: Lithium, Lamictal, and Seroquel are not controlled substances.
The Ryan Haight Act—a federal law requiring an in-person medical evaluation before prescribing controlled substances online—does not apply to non-controlled bipolar medications. These mood stabilizers fall into the same legal category as antidepressants, meaning providers can prescribe them via telehealth without special DEA restrictions.
While the DEA has extended temporary telehealth flexibilities for controlled substances through December 31, 2026, this primarily affects stimulants, opioids, and benzodiazepines. For bipolar treatment with standard mood stabilizers, no federal law prohibits telehealth prescribing, and providers have been able to do this legally for years—not just during the pandemic.
Even though federal law allows telehealth prescribing of bipolar medications, each state sets its own telemedicine standards. These can include:
The good news? No state currently prohibits telehealth prescribing of non-controlled bipolar medications. However, the specifics of how it’s done can vary.
California allows mental health providers to prescribe bipolar medications entirely through telehealth, with no in-person visit requirement. A standard telehealth examination—conducted via secure video—satisfies the state’s ‘appropriate prior examination’ standard.
Recent legislative proposals (AB 1503) would further clarify that asynchronous screenings (like digital questionnaires) can supplement telehealth evaluations, making access even more convenient.
Nurse practitioners in California are transitioning to full independent practice authority under AB 890, meaning experienced NPs can prescribe bipolar medications without physician oversight by 2026.
Texas explicitly permits telehealth prescribing for mental health conditions, including bipolar disorder. Providers can prescribe Lithium, Lamictal, and Seroquel without requiring an in-person visit.
However, nurse practitioners in Texas must work under a prescriptive authority agreement with a collaborating physician. This doesn’t prevent them from treating bipolar disorder via telehealth—it simply means an MD or DO oversees their prescribing practice.
New York allows full telehealth treatment for bipolar disorder with non-controlled medications—no in-person visit needed. Nurse practitioners who have completed 3,600 hours of supervised practice can prescribe independently, making access easier for patients across the state.
In May 2025, New York adopted stricter rules for controlled substances prescribed via telehealth (requiring in-person evaluations with certain exceptions), but this does not affect standard bipolar medications like Lithium or Lamictal.
Florida permits telehealth prescribing of bipolar medications without in-person requirements for non-controlled drugs. However, nurse practitioners must practice under a physician protocol for most psychiatric prescribing (limited independent authority exists only for primary care).
The state restricts telehealth prescribing of Schedule II controlled substances except for psychiatric treatment and certain other exceptions—but again, this doesn’t impact the three most common bipolar medications.
New Hampshire’s recent legislation (SB 252, 2025) expanded telehealth prescribing while adding a unique requirement: if you receive ongoing telehealth prescriptions, you must have at least one evaluation per year. The good news? That annual evaluation can be conducted via telehealth—it doesn’t have to be in-person.
This law particularly benefits patients who need controlled medications (like certain anti-anxiety drugs), but it applies across the board to ensure continuity of care.
Delaware: Full telehealth prescribing allowed; NPs gain independent practice after two years of collaboration.
Pennsylvania: Telehealth permitted with no in-person mandate, though NPs currently require physician collaboration (pending legislation may change this).
Illinois: Telehealth-friendly; experienced NPs can practice independently after 4,000+ hours.
Georgia and Alabama: Collaborative NP practice models; telehealth prescribing allowed under standard care guidelines.
DEA Schedule: None (unscheduled)
Telehealth Prescribable: ✅ Yes, in all states
Typical Supply: 30–90 days with refills
Lithium is the gold-standard mood stabilizer for bipolar disorder and carries no controlled substance restrictions. Providers can prescribe it via telehealth just as they would any other non-controlled medication.
Important clinical note: While legally straightforward, Lithium requires periodic blood tests to monitor levels and check kidney and thyroid function. Your telehealth provider will order lab work that you’ll complete at a local facility—this monitoring is a medical best practice, not a legal requirement.
DEA Schedule: None (unscheduled)
Telehealth Prescribable: ✅ Yes, in all states
Typical Supply: 30–90 days with refills
Lamictal is widely used for bipolar depression and mood stabilization. Because it’s not a controlled substance, no special legal restrictions apply to telehealth prescribing.
Providers typically start with smaller initial supplies due to the need for gradual dose titration (to prevent serious rash reactions), but this is clinical prudence rather than legal mandate.
DEA Schedule: None (unscheduled)
Telehealth Prescribable: ✅ Yes, in all states
Typical Supply: 30–90 days with refills
Seroquel, an atypical antipsychotic used for bipolar mania and mixed episodes, is also not controlled by the DEA. While it has some misuse potential (leading some states to track it in prescription monitoring programs), it remains fully prescribable via telehealth without special legal barriers.
Responsible providers may check your prescription history as a precaution and will monitor for metabolic side effects like weight gain or blood sugar changes.
A legitimate telehealth evaluation for bipolar disorder should mirror the thoroughness of an in-person visit. Expect your provider to:
This typically takes 45–60 minutes for an initial assessment. If a provider rushes through questions or promises medications before completing a full evaluation, that’s a red flag.
Once your provider determines medication is appropriate, they’ll send an electronic prescription to your pharmacy of choice. Many states now mandate e-prescribing for all medications, which actually enhances safety and convenience.
For stable, ongoing treatment, providers often prescribe 90-day supplies with refills. However, expect more frequent check-ins (typically every 1–3 months) to:
Quality telehealth providers emphasize continuity of care. Your treatment plan should include:
Regular video check-ins: Monthly or quarterly visits to assess mood stability
Lab monitoring: As clinically indicated (essential for Lithium, recommended for Seroquel)
Crisis planning: Emergency contacts and procedures if symptoms worsen
Therapy integration: Many providers recommend concurrent psychotherapy, which can also be delivered via telehealth
At Klarity Health, we ensure every patient has transparent pricing (whether using insurance or paying cash), access to licensed providers in their state, and clear follow-up schedules—because consistent monitoring is key to successful bipolar management.
Yes, and in many states, they can do so independently. As of 2025, over 30 states grant nurse practitioners full practice authority, meaning they can diagnose bipolar disorder and prescribe medications without physician oversight.
In states with collaborative practice models (like Texas, Florida, and Pennsylvania), NPs must have formal agreements with supervising physicians—but they can still provide comprehensive bipolar care through telehealth platforms.
Why this matters: NPs often have more availability than psychiatrists, reducing wait times. Since bipolar medications are not controlled substances, NPs face fewer prescriptive restrictions compared to prescribing stimulants for ADHD. This makes them an excellent option for accessible mental healthcare.
Most states operate Prescription Drug Monitoring Programs (PDMPs) to track controlled substance prescriptions. Lithium, Lamictal, and Seroquel are not included in these databases since they’re not controlled.
However, responsible telehealth providers may still check PMPs to see if you’re taking controlled medications (like benzodiazepines or opioid pain relievers) that could interact with your bipolar treatment or signal co-occurring conditions needing attention.
Some states have flagged quetiapine (Seroquel) as a ‘drug of concern’ due to occasional misuse, so providers may exercise extra caution—but this doesn’t create legal barriers to prescribing it via telehealth.
Telehealth works well for:
Telehealth may not be appropriate if you’re experiencing:
Reputable providers will refer you to higher-level care when needed. This isn’t a limitation of telehealth—it’s responsible clinical practice.
As telehealth has grown, so have concerns about ‘pill mill’ practices. The Department of Justice has prosecuted several companies for inappropriate prescribing, particularly of controlled substances.
Warning signs to avoid:
Reputable platforms (like Klarity Health) will:
The DEA’s temporary telehealth flexibilities for controlled substances have been extended through December 31, 2026. This extension primarily affects ADHD stimulants, buprenorphine for opioid use disorder, and benzodiazepines—not standard bipolar medications.
However, several bills in Congress (including the Telehealth Modernization Act) aim to establish permanent frameworks for telehealth prescribing. While these focus on controlled substances, they signal broad bipartisan support for expanding telemedicine access.
California is considering AB 1503, which would codify flexible telehealth examination standards, including asynchronous components.
Pennsylvania has pending legislation to grant nurse practitioners full practice authority (currently stalled but likely to resurface).
Several states are reviewing whether to require periodic in-person visits for certain long-term telehealth treatments, though none currently mandate this for bipolar medications specifically.
For patients seeking bipolar treatment with Lithium, Lamictal, or Seroquel, the regulatory landscape is stable. These medications face no immediate threat of new restrictions, as policy debates center on controlled substances with abuse potential.
However, staying informed about your state’s telehealth rules—and choosing providers who comply with all applicable regulations—protects you from any future changes.
Do I need insurance to get bipolar medications through telehealth?
No. Many telehealth platforms (including Klarity Health) accept both insurance and cash-pay options with transparent pricing. Medication costs at the pharmacy depend on your coverage, but generic versions of Lithium, lamotrigine, and quetiapine are typically affordable.
Can I get a 90-day supply of my bipolar medication via telehealth?
Often, yes—especially if you’re stable on a medication. Providers may start with 30-day supplies for new prescriptions, then extend to 90 days once they’ve confirmed the medication is working well and you’re tolerating it appropriately.
Will my employer or family know I’m getting bipolar treatment online?
Telehealth services must comply with HIPAA privacy regulations. Your medical information is confidential. If you’re using insurance, your insurer will have records of claims, but employers do not receive details about specific diagnoses or medications.
What happens if I move to a different state?
Your provider must be licensed in the state where you’re physically located during the appointment. If you move, you’ll need to connect with a provider licensed in your new state. Most national telehealth platforms can facilitate this transition.
Can I combine telehealth medication management with in-person therapy?
Absolutely. Many patients see a local therapist in person while receiving medication management via telehealth (or vice versa). Coordinated care often produces the best outcomes, and providers can communicate with your consent.
If you’ve been hesitant to seek treatment due to scheduling challenges, transportation barriers, or limited local psychiatric availability, telehealth offers a proven solution. The legal framework is clear: you can access evidence-based bipolar medications through virtual care in all 50 states.
At Klarity Health, we connect you with licensed psychiatrists and psychiatric nurse practitioners who specialize in mood disorders. Our providers conduct thorough evaluations, create personalized treatment plans, and offer ongoing support—all from the comfort of your home.
What sets Klarity apart:
Don’t let geography or logistics stand between you and effective bipolar treatment. Schedule your evaluation today and discover how telehealth can make managing bipolar disorder more convenient and accessible.
U.S. Department of Health and Human Services. (2026, January 2). HHS and DEA extend telemedicine flexibilities for controlled substances through December 31, 2026. HHS Press Room. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Drug Enforcement Administration. (2024, November 15). DEA and HHS extend telemedicine flexibilities through 2025. DEA Announcements. https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall
Sheppard, Mullin, Richter & Hampton LLP. (2025, August 15). Telehealth and in-person visits: Tracking federal and state updates on pandemic-era flexibilities. JD Supra. https://www.jdsupra.com/legalnews/telehealth-and-in-person-visits-6106096/
Texas Board of Nursing. (2025). Advanced practice registered nurse (APRN) frequently asked questions. Texas Board of Nursing Official Site. https://www.bon.texas.gov/faqpracticeaprn.asp.html
Nurse Practitioner Online. (2025, October 3). Nurse practitioner practice authority updates by state – 2025 analysis. https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/
Medical Disclaimer: This article provides legal and general educational information about telehealth prescribing regulations. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider about your specific condition and treatment options.
Find the right provider for your needs — select your state to find expert care near you.